US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% SNDK $1,719.99 ▲+0.00% NVDA $233.95 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% MSTR $160.01 ▲+0.00%
FinancialContent

Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

19.10 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anika Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Therapeutics: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Outlook For Anika Therapeutics ↗
 
Via Benzinga
News headline image
Recap: Anika Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 13, 2024 ↗
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
Via Benzinga
News headline image
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in Upcoming Investor Conferences
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index ↗
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. 
Via Investor's Business Daily
Topics Stocks
News headline image
3 Sorry Penny Stocks to Sell in August Before It’s Too Late ↗
As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail. 
Via InvestorPlace
News headline image
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023 ↗
 
Via Benzinga
News headline image
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Enters Into Cooperation Agreement with Caligan Partners
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Files Preliminary Proxy Statement
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >